SeaStar Medical Reports Positive Results for QUELIMMUNE
DENVER, July 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today positive...
DENVER, July 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today positive...
Tirzepatide produced similar benefits in people with chronic kidney disease as it did in people without and showed signs of...
Coherus BioSciences shared final data from its Phase II trial of casdozokitug, showing a 17.2 percent complete response rate in...
Chemomab Therapeutics (Nasdaq: CMMB), which is developing treatments for fibro-inflammatory (scarring) diseases, rose 14% on Friday and is up...
CVAC System (Photo: Business Wire)CVAC System ProcedureMulti-Center ASPIRE 1-Year Study Results Show Healthcare Consumption Events are Significantly Lower after SURE...